NCT00249444View on ClinicalTrials.gov

Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Cocaine DependenceDepression
Interventions
DRUG

Mirtazapine

Mirtazapine

DRUG

Placebo

placebo

Trial Locations (1)

10032

Research Foundation for Mental Hygiene, Inc., New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00249444 - Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression | Biotech Hunter | Biotech Hunter